Target Name: GPR85
NCBI ID: G54329
Review Report on GPR85 Target / Biomarker Content of Review Report on GPR85 Target / Biomarker
GPR85
Other Name(s): Super conserved receptor expressed in brain 2 | Seven transmembrane helix receptor | G protein-coupled receptor 85 | seven transmembrane helix receptor | SREB2 | Probable G-protein coupled receptor 85 | G protein-coupled receptor 85, transcript variant 1 | GPR85 variant 1 | GPR85_HUMAN | super conserved receptor expressed in brain 2 | SREB

GPR85: A Drug Target / Disease Biomarker

GPR85 is a G protein-coupled receptor (GPCR) that is expressed in various tissues and cells in the body. It is involved in several physiological processes, including sensory perception, neurotransmitter signaling, and hormone regulation. GPR85 has also been identified as a potential drug target and biomarker for several diseases, making it a promising target for drug development.

GPR85 is a member of the GPCR family, which includes over 700 different proteins that are involved in various signaling pathways in the body. GPCR signaling involves the interaction between a GPCR protein and a ligand, which leads to the production of a response signal. The GPCR signaling pathway is highly conserved across different species and is involved in the regulation of a wide range of physiological processes, including sensory perception, neurotransmitter signaling, and hormone regulation.

GPR85 is a GPCR that is expressed in various tissues and cells in the body, including the brain, spinal cord, heart, and liver. It is involved in the regulation of pain perception, neurotransmitter signaling, and hormone regulation. GPR85 has also been shown to be involved in the regulation of stress and anxiety responses.

GPR85 is a potential drug target because of its involvement in several diseases, including pain, anxiety, and neurodegenerative disorders. GPR85 has been shown to be involved in the regulation of pain perception and neurotransmitter signaling, making it a potential target for pain medications. Additionally, GPR85 has been shown to be involved in the regulation of anxiety and stress responses, making it a potential target for anxiety and stress disorders.

GPR85 is also a potential biomarker for several diseases, including cancer, neurodegenerative disorders, and cardiovascular disease. The identification of GPR85 as a potential biomarker for these diseases makes it a promising target for diagnostic tools and therapeutic interventions.

GPR85 has also been shown to play a role in the regulation of reproductive processes. GPR85 has been shown to be involved in the regulation of ovulation and fertility in both humans and animals. This suggests that GPR85 may be a potential target for therapies that are aimed at improving reproductive health.

In conclusion, GPR85 is a GPCR that is involved in several physiological processes in the body. Its potential as a drug target and biomarker makes it a promising target for drug development. Further research is needed to fully understand the role of GPR85 in the regulation of pain, anxiety, neurodegenerative disorders, and reproductive processes.

Protein Name: G Protein-coupled Receptor 85

Functions: Orphan receptor

The "GPR85 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPR85 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GPR87 | GPR88 | GPR89A | GPR89B | GPRACR | GPRASP1 | GPRASP2 | GPRASP3 | GPRC5A | GPRC5B | GPRC5C | GPRC5D | GPRC5D-AS1 | GPRC6A | GPRIN1 | GPRIN2 | GPRIN3 | GPS, PLAT and transmembrane domain-containing protein | GPS1 | GPS2 | GPS2P1 | GPSM1 | GPSM2 | GPSM3 | GPT | GPT2 | GPX1 | GPX1P1 | GPX2 | GPX3 | GPX4 | GPX5 | GPX6 | GPX7 | GPX8 | GRAMD1A | GRAMD1B | GRAMD1C | GRAMD2A | GRAMD2B | GRAMD4 | GRAMD4P2 | GRAMD4P5 | GRAMD4P7 | Granzyme | GRAP | GRAP2 | GRAPL | GRAPL-AS1 | GRASLND | GRB10 | GRB14 | GRB2 | GRB7 | GREB1 | GREB1L | GREM1 | GREM1-AS1 | GREM2 | GREP1 | GRHL1 | GRHL2 | GRHL3 | GRHL3-AS1 | GRHPR | GRIA1 | GRIA2 | GRIA3 | GRIA4 | GRID1 | GRID2 | GRID2IP | GRIFIN | GRIK1 | GRIK1-AS1 | GRIK1-AS2 | GRIK2 | GRIK3 | GRIK4 | GRIK5 | GRIN1 | GRIN2A | GRIN2B | GRIN2C | GRIN2D | GRIN3A | GRIN3B | GRINA | GRIP1 | GRIP2 | GRIPAP1 | GRK1 | GRK2 | GRK3 | GRK4 | GRK5 | GRK6 | GRK7 | GRM1 | GRM2